EVOK (Evoke Pharma) Days Inventory : 362.68 (As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Evoke Pharma Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Evoke Pharma's Average Total Inventories for the three months ended in Dec. 2024 was $0.47 Mil. Evoke Pharma's Cost of Goods Sold for the three months ended in Dec. 2024 was $0.12 Mil. Hence, Evoke Pharma's Days Inventory for the three months ended in Dec. 2024 was 362.68.

The historical rank and industry rank for Evoke Pharma's Days Inventory or its related term are showing as below:

EVOK' s Days Inventory Range Over the Past 10 Years
Min: 233.66 Med: 475.22 Max: 990.11
Current: 525.19

During the past 13 years, Evoke Pharma's highest Days Inventory was 990.11. The lowest was 233.66. And the median was 475.22.

EVOK's Days Inventory is ranked worse than
95.38% of 931 companies
in the Drug Manufacturers industry
Industry Median: 160.35 vs EVOK: 525.19

Evoke Pharma's Days Inventory declined from Dec. 2023 (763.25) to Dec. 2024 (362.68).

Inventory Turnover measures how fast the company turns over its inventory within a year. Evoke Pharma's Inventory Turnover for the three months ended in Dec. 2024 was 0.25.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Evoke Pharma's Inventory-to-Revenue for the three months ended in Dec. 2024 was 0.14.

Evoke Pharma Days Inventory Historical Data

The historical data trend for Evoke Pharma's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evoke Pharma Days Inventory Chart

Evoke Pharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Inventory

Get a 7-Day Free Trial

990.11

234.80

233.66

696.57

475.22

Evoke Pharma Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Days Inventory	Get a 7-Day Free Trial															763.25	531.13	1,261.92	455.37	362.68

Competitive Comparison of Evoke Pharma's Days Inventory

For the Drug Manufacturers - Specialty & Generic subindustry, Evoke Pharma's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evoke Pharma's Days Inventory Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Evoke Pharma's Days Inventory distribution charts can be found below:

* The bar in red indicates where Evoke Pharma's Days Inventory falls into.

Save Embed

;

Save Embed

;

Evoke Pharma Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Evoke Pharma's Days Inventory for the fiscal year that ended in Dec. 2024 is calculated as

	Days Inventory (A: Dec. 2024 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2023 )	+	Total Inventories (A: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2024 )	*	Days in Period
=	( (0.482	+	0.445)	/	2 )	/	0.356	*	365
=	0.4635					/	0.356	*	365
=	475.22

Evoke Pharma's Days Inventory for the quarter that ended in Dec. 2024 is calculated as:

	Days Inventory (Q: Dec. 2024 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Sep. 2024 )	+	Total Inventories (Q: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
=	( (0.493	+	0.445)	/	2 )	/	0.118	*	365 / 4
=	0.469					/	0.118	*	365 / 4
=	362.68

Evoke Pharma (NAS:EVOK) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Evoke Pharma's Inventory Turnover for the three months ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.118	/	0.469
	=	0.25

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Evoke Pharma's Inventory to Revenue for the three months ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.469	/	3.308
	=	0.14

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Evoke Pharma Days Inventory Related Terms

Thank you for viewing the detailed overview of Evoke Pharma's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Evoke Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Evoke Pharma Inc (NAS:EVOK) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

420 Stevens Avenue, Suite 230, Solana Beach, CA, USA, 92075

Website

https://www.evokepharma.com

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Executives

Vickie S Reed	director	TORREYPINES THERAPEUTICS, INC., 11085 NORTH TORREY PINES RD, STE 300, LA JOLLA CA 92037
David A Gonyer	director, officer: President and CEO	C/O EVOKE PHARMA, INC., 505 LOMAS SANTA FE DRIVE, SOLANA BEACH CA 92075
Matthew J D'onofrio	officer: Exec VP, Chief Bus. Officer	C/O EVOKE PHARMA, INC., 505 LOMAS SANTA FE DRIVE, SOLANA BEACH CA 92075
Lvp Gp Iii, Llc	10 percent owner	ONE EMBARCADERO CENTER SUITE 4050, SAN FRANCISCO CA 94111
Kenneth J Widder	director, 10 percent owner	10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Dp Vii Associates Lp	10 percent owner	ONE PALMER SQ, STE 515, PRINCETON NJ 08542
Domain Parters Vii L P	10 percent owner	ONE PALMER SQUARE SUITE 515, PRINCETON NJ 08542
Nimesh Shah	10 percent owner	12481 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO CA 92130
Marilyn R. Carlson	officer: Chief Medical Officer	C/O EVOKE PHARMA, INC., 505 LOMAS SANTA FE DRIVE, SOLANA BEACH CA 92075
Brian H Dovey	10 percent owner	ONE PALMER SQUARE, PRINCETON NJ 08542
Todd C Brady	director	C/O EVOKE PHARMA, INC., 505 LOMAS SANTA FE DRIVE, SOLANA BEACH CA 92075
Scott L Glenn	director
Lvpmc, Llc	10 percent owner	ONE EMBARCADERO CENTER SUITE 4050, SAN FRANCISCO CA 94111
Lvp Iii Partners Lp	10 percent owner	ONE EMBARCADERO CENTER SUITE 4050, SAN FRANCISCO CA 94111
Lvp Iii Associates, L.p.	10 percent owner	ONE EMBARCADERO CENTER SUITE 4050, SAN FRANCISCO CA 94111